CompletedPhase 3

VCMX, PRF and SCTG Treatment in the Gingival Recessions

Turkey (Türkiye)60 participantsStarted 2022-12-01

Plain-language summary

Comparison of Volume-Stable Collagen Matrix, Platelet-Rich Fibrin, and Subepithelial Connective Tissue Graft in the Treatment of Multiple Adjacent Gingival Recessions: A Parallel-Group, Randomized, Controlled Clinical Trial

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ≥2 mm buccal recessions affecting ≥2 adjacent maxillary teeth;
✓. systemically and periodontally healthy;
✓. non-smokers;
✓. Miller Class I-II (no interproximal attachment or CEJ loss);
✓. probing depth (PD) \<3 mm;
✓. GT ≥1 mm;
✓. KGW ≥2 mm;
✓. identifiable CEJ;

Exclusion criteria

✕. smokers;
✕. caries/restorations/abrasions in the treated area, furcation involvement;
✕. contraindications to surgery;
✕. pregnancy or lactation;
✕. medications compromising healing;
✕. surgery in the same region within 2 years;
✕. bleeding disorders;
✕. requirement for antibiotic prophylaxis; and

What they're measuring

Percentage of Complete Root Coverage

Timeframe: 12 Months

Trial details

NCT IDNCT07345520

SponsorBulent Ecevit University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-01

View on ClinicalTrials.gov More Gingival Recession, Localized trials